Ani pharmaceuticals reports first quarter 2021 results

Baudette, minn.--(business wire)--ani pharmaceuticals, inc. (“ani” or the “company”) (nasdaq: anip) today announced business highlights and financial results for the three months ended march 31, 2021. first quarter and recent business highlights: continued efforts to assemble a robust re-filing package for cortrophin® gel in preparation for second-quarter 2021 submission to the u.s. food and drug administration (“fda”). signed a definitive agreement to acquire novitium pharma llc (“novitium”),
ANIP Ratings Summary
ANIP Quant Ranking